MBrace Therapeutics Raises $85 Million Series B Financing to Advance Oncology Pipeline of Innovative Antibody Drug Conjugate Candidates lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.
– Oversubscribed Series B round led by TPG includes prominent group of new and existing investors, bringing total raised to-date to over $110 million– Funding supports rapid clinical development of targeted ADC therapeutics in difficult-to-treat cancers – Chris LeMasters joins as Independent Board Member, bringing 2.
2020 was a pivotal year for healthcare.
The unrelenting attention on the U.S. healthcare system has driven record levels of investor interest, leading to all-time high fundraising amounts and eye-catching mergers and IPOs.
Investors and other industry insiders have maintained that the coronavirus pandemic, for all its devastation and upheaval, pushed the healthcare industry forward 10 years in just six months.
On Wednesday, February 10, we spoke with four top healthcare VCs on what the future of healthcare will look like in 2021 and beyond.
Insider s senior healthcare reporter Megan Hernbroth spoke with:
Andrew Adams, cofounder and managing partner at Oak HC/FT
»
JOIN OUR EVENT FEBRUARY 10: Hear from healthcare s biggest VCs on the future of digital health, biotech, and startups
JOIN OUR EVENT FEBRUARY 10: Hear from healthcare s biggest VCs on the future of digital health, biotech, and startups
Business InsiderFeb 3, 2021, 22:49 IST
Oak HC/FT; Venrock; CRV; Menlo Ventures; Samantha Lee/Business Insider
By most measures, 2020 was a pivotal year for healthcare. The coronavirus pandemic upended U.S.
healthcare as we know it, highlighting brutal disparities in quality and access to care while pushing many hospitals to the financial brink. There was also a historically fast vaccine development and emergency authorization process, and large-scale testing the likes of which the United States had never attempted before.